iiinova — where your digital self keeps evolving

Reposted by Devin Effinger, Ph.D

Melissa Herman @melissaherman.bsky.social · 01/05/2026

So fun to be part of such a rockstar panel with @rcbagot.bsky.social @mayoonthebrain.bsky.social and Friede Holze. If you look carefully you can see @deffinger.bsky.social 👀 whose beautiful work is now in press at Nature Communications 🧠

0103

Reposted by Devin Effinger, Ph.D

Susanne Ahmari @ahmarilab.bsky.social · 13/01/2026

@deffinger.bsky.social at Lived Experience Panel @acnporg.bsky.social #ACNP2026: We should be going from consultation to co-production in the integration of lived experience in research 🧠🧪

0108

Reposted by Devin Effinger, Ph.D

NPP-Digital Psychiatry and Neuroscience (DPN) @dpn-journal.bsky.social · 05/01/2026

Our first Deep Dive of 2026 covers a Perspective calling for recognizing & removing barriers faced by researchers with lived experience of mental illness or SUDs who work in our field. By @umarchatterjee.bsky.social @mayaschumer.bsky.social @deffinger.bsky.social & colleagues youtu.be/y5fymczeNFc

youtu.be

The central role of lived experience in mental health research

YouTube video by NPP - Digital Psychiatry and Neuroscience (DPN)

194

Devin Effinger, Ph.D @deffinger.bsky.social · 21/11/2025

My TEDx talk is live! It blends my story—from TBI to addiction to neuroscience—with practical tools for stronger emotional control and brain optimization. I’d be grateful if you shared it. www.youtube.com/watch?v=08Lg...

youtube.com

Getting Unstuck: Moving Towards Better Mental Health | Dr. Devin Effinger | TEDxBoulder

YouTube video by TEDx Talks

080

Reposted by Devin Effinger, Ph.D

NPP-Digital Psychiatry and Neuroscience (DPN) @dpn-journal.bsky.social · 13/11/2025

A powerful DPN Perspective from @umarchatterjee.bsky.social, @mayaschumer.bsky.social, @deffinger.bsky.social, @viscidula.bsky.social, Noel Vest, Michael Cahill, Brandon Staglin, & @ericjnestler.bsky.social. DPN is grateful for the authors' dedication to writing this!

074

Devin Effinger, Ph.D @deffinger.bsky.social · 02/10/2025

If anyone is looking for a roommate (or knows of someone) and has a room at the Atlantis for @acnporg.bsky.social please let me know!

000

Reposted by Devin Effinger, Ph.D

Scott Thompson, PhD @sthom003.bsky.social · 22/08/2025

We still don’t know if microdosing psychedelics is effective or a placebo, but is it safe? Could microdosing activate cardiac 5HT2B receptors and cause valvulopathy? New work online at pubs.acs.org/doi/pdf/10.1... from @deffinger.bsky.social suggests that - at least in mice - the answer is no. 1/

pubs.acs.org

3197

Reposted by Devin Effinger, Ph.D

Uma R. Chatterjee, M.S., MHPS @umarchatterjee.bsky.social · 12/08/2025

THRILLED to share @acnporg.bsky.social news x2! 1) Our study group “Centering Lived Experience in Psychiatric Neuroscience Research” @ericjnestler.bsky.social @mayaschumer.bsky.social @deffinger.bsky.social @viscidula.bsky.social @noelvest.bsky.social @cahill-lab.bsky.social=ACCEPTED! 🤩 #ACNP2026

33413

Reposted by Devin Effinger, Ph.D

Maya Schumer! @mayaschumer.bsky.social · 13/08/2025

@acnporg.bsky.social brought @umarchatterjee.bsky.social @deffinger.bsky.social & me together last year: After finding each other on X-as we are all public/open about our lived experience -we met+discussed the ideas for this Study Group! Looking forward to doing this work together@ #ACNP2026💥🧠❤️

043

Devin Effinger, Ph.D @deffinger.bsky.social · 31/07/2025

It’s wild how much change is possible in this life. From relearning to talk post-TBI, to full blown heroin addiction, to a life beyond anything I could have imagined. Im very fortunate to not only be alive, but to have been selected to speak at 2025 TEDxBoulder!

4287

Devin Effinger, Ph.D @deffinger.bsky.social · 18/07/2025

The inaugural #GRCPsychedelics was a success! I am honored to have been one of a few chosen to receive a travel award and be able to share the stage with the leaders in the field. 🙏 to the organizers! @alexkwan.bsky.social @vyazovskiy.bsky.social @melissaherman.bsky.social @viditavaidya.bsky.social

3349

Devin Effinger, Ph.D @deffinger.bsky.social · 04/05/2025

It’s a common misconception that, for the person with a SUD, the substances are the problem. In my experience, the real problem was much deeper. Until I addressed the underlying causes/conditions, longterm sobriety was unattainable. Link in bio. #sober #sobriety #sobersky #recovery

0112

Devin Effinger, Ph.D @deffinger.bsky.social · 25/04/2025

Was on a podcast recently where I dive into the neuroscience of addiction, psychedelics, and healing—from both the science and my lived experience. Grateful for the chance to share my journey and the science behind what’s actually going on in the brain. Check it out: youtu.be/uNXrbEuturY

youtu.be

Neuroscience, Addiction, 12 Steps with Dr. Devin Effinger & Sarah Pritchard - PART 1

YouTube video by Impacting Recovery - Uncensored

0165

Devin Effinger, Ph.D @deffinger.bsky.social · 14/04/2025

People have warned about #psychedelics and 5-HT2B receptor activation for years — citing potential cardiotoxicity. But no one had tested it. Until now. We used echocardiography to assess cardiac risk after chronic LSD microdosing in mice. @sthom003.bsky.social www.biorxiv.org/content/10.1...

biorxiv.org

Assessing the potential cardiovascular risk of microdosing the psychedelic LSD in mice

Microdosing, the prolonged ingestion of psychedelics at sub-hallucinogenic doses, has gained popularity for its perceived cognitive and emotional benefits. Psychedelics have high affinity for 5-HT2B r...

094

Devin Effinger, Ph.D @deffinger.bsky.social · 04/02/2025

Winter brain 2025 was a blast! Our panel on microdosing #psychedelics was the most attended session of the conference. We covered 4 distinct areas: anecdotal/lived experience, preclinical neuroscience, clinical, and cardiovascular risk. Most people stayed after for a great discussion. #WCBR2025

0212

Devin Effinger, Ph.D @deffinger.bsky.social · 27/01/2025

Are you @winter_brain ?? Come check out our panel this afternoon on microdosing #psychedelics. Including lived experience, preclinical effects, clinical effects, and my work utilizing rodent echocardiogram to assess potential cardiovascular risks. #WCBR2025 🍄 @sthom003.bsky.social

091

Devin Effinger, Ph.D @deffinger.bsky.social · 25/01/2025

Just getting into Tahoe. Who’s at Winter Brain??

120

Reposted by Devin Effinger, Ph.D

Bita Moghaddam @bita137.bsky.social · 16/01/2025

An amazing honor to give NIH’s WALS lecture today as the last speaker under the leadership of NIH Director Dr Monica Bertagnolli

21019

Reposted by Devin Effinger, Ph.D

Britton Barbee @brittonrae.bsky.social · 10/01/2025

Great PDA seminars today by @deffinger.bsky.social and Jill King 🐭💊🧠

152

Reposted by Devin Effinger, Ph.D

Scott Thompson, PhD @sthom003.bsky.social · 18/12/2024

The Senate Committee on Health, Education, Labor, and Pensions, led by Senator Bill Cassidy (R-LA) - a gastroenterologist with an MD from LSU, just released a report entitled NIH IN THE 21st CENTURY: ENSURING TRANSPARENCY AND AMERICAN BIOMEDICAL LEADERSHIP. Since he is the ranking Republican, 1/n

13125

Reposted by Devin Effinger, Ph.D

Melissa Herman @melissaherman.bsky.social · 12/12/2024

#ACNP2024 highlight... getting to see @deffinger.bsky.social and share his exciting data 🧠🧠🧠

1365

Devin Effinger, Ph.D @deffinger.bsky.social · 11/12/2024

On tonight: Given that classical #psychedelics are 5-HT2B agonists, there is concern of a potential cardiovascular risk with prolonged use. To resemble human context, we chronically administered 2 low doses of LSD and performed echocardiograms at baseline, 4-, and 8-weeks. #ACNP2024

4246

Reposted by Devin Effinger, Ph.D

Scott Thompson, PhD @sthom003.bsky.social · 07/12/2024

More specifically, on Monday afternoon you do not want to miss #ACNP2024 ’s only panel dedicated to an oxymoron: non-psychedelic psychedelics! It will be a trip! Or not….

0182

Devin Effinger, Ph.D @deffinger.bsky.social · 07/12/2024

Hello @acnporg.bsky.social! I am a postdoc interested in the intersection of neurobiological effects of trauma and #psychedelic mechanism of action. 1st time here. I’ll be presenting data investigating the cardiovascular effects of chronic, low-dose LSD in mice Wed night! Let’s connect!

1113

Reposted by Devin Effinger, Ph.D

Psychedelic Brain Science @psychedbrainsci.bsky.social · 06/12/2024

Our most recent episode featured @deffinger.bsky.social discussing threat processing, the amygdala + psychedelics Check it out here: www.psychedelicbrainscience.com/podcast/epis...

psychedelicbrainscience.com

Podcast | Your Brain on Science

Psychedelic science podcast delving into past, present, and future findings in a fun and accessible way

021

Reposted by Devin Effinger, Ph.D

Alaina Jaster, PhD @jasteralaina.bsky.social · 03/12/2024

Our final episode in the #psychedelic circuitry series!! And maybe the year?? This episode dives into threat, amygdala, PVN + how psychedelics alter these responses in male and females animal models! Featuring @deffinger.bsky.social ! www.psychedelicbrainscience.com/podcast/epis...

psychedelicbrainscience.com

Podcast | Your Brain on Science

Psychedelic science podcast delving into past, present, and future findings in a fun and accessible way

0144

Devin Effinger, Ph.D @deffinger.bsky.social · 15/11/2024

Huberman: cold plunge promotes a massive release in dopamine Lay public: cold plunge makes you happier Scientists: peripheral dopamine doesn’t cross the blood brain barrier. 😂 🤦🏻‍♂️

170